Advanced Functional Materials · 2024 · 65 citations · 39 references
Life SciencesImmunologyOncologyDrug DeliveryImmunotherapyTumor ImmunologyCancer ImmunotherapyImmune Cell InfiltrationMagnetic-responsive Drug DeliveryNanomedicineT Cell Responses To TumorsTumor-infiltrating LymphocytesAntitumor Immune ActivationCancer Immunotherapy NanoparticlesCell InfiltrationImmune Cell ActivationImmune Privilege InductionIntracellular PenetrationTumor Immune Cell InfiltrationTumor-targeted Drug Delivery
Abstract T lymphocytes play a central role in immunotherapy, utilizing physical interactions to actively inhibit the development of metastases. However, tumor immune privilege and heterogeneity pose challenges by protecting against immune attacks and limiting immune cell infiltration into tumors, particularly in invasive metastatic clusters. Here, a tumor penetrating magnetic particles (TUP) containing the cascade‐responsive cell membrane‐mimetic copolymer (zwitterionic 2‐methacryloyloxyethyl phosphorylcholine‐co‐3‐hydroxypyridin‐4‐one, PH) and cuproptosis molecules (elesclomol‐copper, EsCu) for programming T cell infiltration is developed. The intravenously injected TUP accumulates at the tumor via the charge conversion of PH and hyperthermia effects of TUP. In metastatic clusters, ES and Cu, triggered by intracellular environments and hyperthermia, are readily released. ES and Cu simultaneously induce cuproptosis of cancer cells and stimulate immune responses. This process destroys self‐defense mechanisms and exacerbates cytotoxicity. The therapies facilitate the release of tumor‐associated antigens, including neoantigens and damage‐associated molecular patterns. Following this, the 3‐hydroxypyridin‐4‐one groups on TUP act as antigen reservoirs, transporting autologous tumor‐associated antigens to dendritic cells, thereby inducing prolonged immune activation. TUP acts as an antigen reservoir in copper apoptosis‐mediated lung metastasis, promoting the accumulation of immune cells in metastatic clusters and effectively preventing the progression of metastatic tumors.
39
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Yuanzeng Min, Kyle C. Roche, Shaomin Tian et al. · Nature Nanotechnology · 2017 · 689 citations
Life Sciences, Immunology, Oncology +16